Clinton Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-8,136
Closed -$241K 682
2017
Q1
$241K Sell
8,136
-23,973
-75% -$654K 0.01% 823
2016
Q4
$797K Sell
32,109
-12,899
-29% -$293K 0.05% 423
2016
Q3
$1.02M Sell
45,008
-45,496
-50% -$1.07M 0.05% 461
2016
Q2
$2.16M Buy
90,504
+56,201
+164% +$1.35M 0.09% 301
2016
Q1
$815K Buy
+34,303
New +$839K 0.05% 476

Other funds holding GMED

Clinton Group's GMED Position: Q2 2017 in Review

Clinton Group sold out of Globus Medical (GMED) in Q2 2017, closing a stake of 8,136 shares — an estimated $241K sold.

Clinton Group first reported a position in GMED in Q1 2016 and held it in 5 quarters. The position peaked at $2.16M in Q2 2016. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

  • Clinton Group reported no remaining Globus Medical position as of Q2 2017 after selling out during the quarter.
  • Clinton Group sold 8,136 Globus Medical shares in Q2 2017, an estimated $241K.
  • Clinton Group first reported a position in Globus Medical in Q1 2016 and held it in 5 quarters.
  • Clinton Group's Globus Medical position peaked at $2.16M in Q2 2016.
  • 244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.